News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Weber Kathleen Gallagher
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/09/2023 |
4
| Weber Kathleen Gallagher (Chief Product Officer) has filed a Form 4 on ORASURE TECHNOLOGIES INC
Txns:
| Paid exercise price by delivering 6,857 shares
@ $4.875, valued at
$33.4k
|
|
01/07/2022 |
4
| Weber Kathleen Gallagher (President - Molecular Sol) has filed a Form 4 on ORASURE TECHNOLOGIES INC
Txns:
| Granted 60,901 shares
@ $8.21, valued at
$500k
|
|
02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2020 |
4
| Weber Kathleen Gallagher (EVP & BU Lead - Molecular) has filed a Form 4 on ORASURE TECHNOLOGIES INC
Txns:
| Paid exercise price by delivering 1,536 shares
@ $7.165, valued at
$11k
Paid exercise price by delivering 901 shares
@ $7.165, valued at
$6.5k
Paid exercise price by delivering 1,467 shares
@ $7.165, valued at
$10.5k
Granted 32,516 shares
@ $7.165, valued at
$233k
Granted 10,238 shares
@ $7.165, valued at
$73.4k
Paid exercise price by delivering 3,023 shares
@ $7.165, valued at
$21.7k
Paid exercise price by delivering 2,900 shares
@ $7.165, valued at
$20.8k
|
|
02/05/2019 |
4
| Weber Kathleen Gallagher (EVP & BU Lead - Molecular) has filed a Form 4 on ORASURE TECHNOLOGIES INC
Txns:
| Paid exercise price by delivering 2,985 shares
@ $12.9825, valued at
$38.8k
Paid exercise price by delivering 1,260 shares
@ $12.9825, valued at
$16.4k
Paid exercise price by delivering 760 shares
@ $12.9825, valued at
$9.9k
Granted 13,028 shares
@ $0 Granted 20,400 shares
@ $12.9825, valued at
$264.8k
Paid exercise price by delivering 5,809 shares
@ $12.9825, valued at
$75.4k
|
|
01/04/2019 |
3
| Weber Kathleen Gallagher (EVP & BU Lead - Molecular) has filed a Form 3 on ORASURE TECHNOLOGIES INC |
|
|